News

Synta Pharmaceuticals has reported a net loss attributable to common stockholders of $8.5m, or $0.25 per basic and diluted share, for the second quarter in 2009, compared to

The Society of Chemical Manufacturers and Affiliates (SOCMA) has called on Congress to update the Toxic Substances Control Act (TSCA) chemical management regulation, without enacting a complete overhaul.

AlphaRx has entered into a collaboration agreement with Venturepharm to establish a drug development center in China Medical City, in China. It is expected to be used as

DARA BioSciences is collaborating with America Stem Cell (ASC) to expand on observations from recent preclinical studies. The results showed that dipeptidylpeptidase (DPPIV) inhibitors has improved the efficiency

Covidien and Nuvo have reported that FDA has extended the review of Pennsaid diclofenac sodium topical solution under the Prescription Drug User Fee Act (PDUFA). During the review

Aphios has received a phase I Small Business Innovative Research (SBIR) grant from the National Heart Lung and Blood Institute (NHLBI), National Institutes of Health (NIH). The fund

Shanghai ChemPartner (ChemPartner), a wholly-owned subsidiary of ShangPharma, has extended its drug discovery collaboration with Elara. ChemPartner will provide fully integrated services in the areas of DMPK, pharmacology

Oramed Pharmaceuticals has received a government grant of NIS3.1 million from the Office of the Chief Scientist (OCS) at the Ministry of Industry, Trade and Labor of Israel.

Eiger has acquired exclusive worldwide license to novel Hepatitis C Virus (HCV) technology from the Stanford University. The technology is focused on a variety of novel targets, including